Glucagon-like peptide-1 agonists.
BMJ · 2012
Last updated 2026-05-28| Journal | BMJ, 2012 |
|---|---|
| Citations | 2 |
| Relative citation ratio | 0.05 |
| NIH percentile | 5 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction, Chronic Kidney Disease, Mash, Obstructive Sleep Apnea, Pcos, Heart Failure |
Full record and abstract on PubMed 22236410 ↗